Our Research Library
Dive into over a dozen proprietary studies—mechanistic work, clinical trials, and real-world data demonstrating our formula’s effects.
5x
17.4%
5.4%
Increase in Th17 (IL-17/IL-22) CD4⁺ cells after 15 days of supplementation, with Th2 cells unchanged.
Increase in CD8⁺ cytotoxic T cells by week 8 in cancer patients, correlating with improved quality of life.
Lengthening of leukocyte telomeres after 8 weeks of supplementation in healthy Thai adults.
Highlights
Study 1 - Immune Support
Study 2 - Cancer Care Support
Study 3 - Longevity & Cellular Health
Drawing on 14 proprietary R&D studies and clinical trials, here’s what our top results show:
Study of the Operation BIM Product on the Modulation of the Immune System (Arthrinox)
All Studies & Trials
Study of the Operation BIM Product on the Modulation of the Immune System (Diabenox)
Lab Data of BIM Capsule and BIM Mangosteen Juice
Xanthones, Natural substances found in the Genus Garcinia, particularly in mangosteen
ByeByeHIV with Thai Innovation
Balancing Immunity with a Dietary Supplement Derived from Five Edible Plants for Management of Rheumatoid Arthritis
การทดสอบเชื้อ HIV ด้วยวิธี HIV-1 Provirus
Balancing Immunity with a Dietary Supplement Derived from Five Edible Plants for Management of Rheumatoid Arthritis
Study of the Operation BIM Mangosteen Juice on the Modulation of the Immune System
Comparison of the Effects of Five Thai Edible Plant Extracts on Canine Mammary Gland Carcinoma Cell Line and Canine Adipose-Derived Mesenchymal Stem Cells
Reduction of Proviral Load of Feline Leukemia Virus Employing the Immunomodulatory Property of Five Thai Edible Plant Extracts
Conducted by Asian Phytoceuticals Public Co. Ltd. (APCO Thailand, MAI-listed) as part of their Operation BIM research program, these 14 proprietary R&D studies and clinical trials dive into every aspect of Th17 & SIB—from targeted immune activation to quality-of-life outcomes and cellular health.